Filing Flows › Comparisons › RPRX vs NRIX
Royalty Pharma vs Nurix Therapeutics: RPRX and NRIX compared
Royalty Pharma is the larger company: $690M of revenue in its latest quarter (Q3 2026) against $673M for Nurix Therapeutics (Q3 FY26). Nurix Therapeutics is growing faster (85× against +13% a year earlier). Nurix Therapeutics is more profitable, with an operating margin of 83.1% against 59.5%.
Where the money goes: RPRX and NRIX
Royalty Pharma (RPRX) · Q3 2026
Royalty Pharma, Q3 2026: revenue $690M (+13% year over year), operating margin 59.5%, net earnings $145M, operating cash flow $686M. The chart follows the revenue to costs, profit and cash.
Nurix Therapeutics (NRIX) · Q3 FY26
Nurix Therapeutics, Q3 FY26: revenue $673M (85× year over year), operating margin 83.1%, net earnings $550M, operating cash flow $616M. The chart follows the revenue to costs, profit and cash.
| Royalty Pharma (RPRX) | Nurix Therapeutics (NRIX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 FY26 |
| Revenue | $690M | $673M |
| Revenue growth, Y/Y | +13% | 85× |
| Operating margin | 59.5% | 83.1% |
| Net earnings | $145M | $550M |
| Net margin | 21.0% | 81.7% |
| Operating cash flow | $686M | $616M |
| Free cash flow | — | $614M |
| Market value | $37.5B | $1.8B |
| P/E | 44.3× | 6.7× |
| Analysts’ mean target | $71.25 | $33.38 |
Where the revenue comes from
Royalty Pharma
- Income from financial royalty assets: $648M (94%)
- Other royalty income and revenues: $42.5M (6%)
Nurix Therapeutics
- License revenue: $653M (97%)
- Collaboration revenue: $19.9M (3%)
Questions
Which is bigger, Royalty Pharma or Nurix Therapeutics?
Royalty Pharma is the larger company: $690M of revenue in its latest quarter (Q3 2026) against $673M for Nurix Therapeutics (Q3 FY26).
Is Royalty Pharma or Nurix Therapeutics growing faster?
Nurix Therapeutics is growing faster (85× against +13% a year earlier).
Which is more profitable, Royalty Pharma or Nurix Therapeutics?
Nurix Therapeutics is more profitable, with an operating margin of 83.1% against 59.5%.
More: Royalty Pharma earnings · how Royalty Pharma makes money · Nurix Therapeutics earnings · how Nurix Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 13, 2026). Fiscal quarters can end on different dates. Not investment advice.